$KN

Knowles (NYSE: KN) director clarifies 6,618-share August sale

Knowles Corp (KN) director Cheryl L. Shavers sold 6,618 shares of common stock on August 17, 2026, at prices around $39.27–$39.28 per share. The amended Form 4/A clarifies these sales were not part of a Rule 10b5-1 trading plan, correcting a prior filing.

Original reporting
Published Aug 19, 2026, 4:06 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 19, 2026, 7:04 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$KN
Neutral
high confidence
Mentioned
$KN
Relevance
4/10
AlphAI data visualization · based on stocktitan.net
Decision brief

The 30-second read

$KNNeutralLow
01

Why it matters

The correction removes any perception of pre‑planned trading, reinforcing transparency but offering no new strategic insight.

02

Market read

A routine insider sale with a filing amendment; limited relevance for traders.

03

What to watch

The amendment clarifies compliance, but the sale size is too small to indicate material insider sentiment.

Relevance 4/10Novelty 4/10Timing: post‑trade August 17, 2026 filing amendment

Background

Form 4/A filing correcting an earlier indication that the sales were part of a 10b5‑1 plan.

Company-level read

Ticker impact

$KNNeutralHigh confidence
Context

Director Cheryl L. Shavers sold 6,618 shares of Knowles Corp at $39.27‑$39.28 on Aug 17, 2026, and amended the Form 4 to show the trades were not under a 10b5‑1 plan.

Expected impact

Minimal impact; price likely unchanged or slight downward pressure.

Evidence & confidence

Small size relative to market cap and routine nature of the correction suggest limited market reaction.

Market effects

None; the sale does not affect the broader audio/semiconductor sector.

No regional effect; limited to Knowles shareholders.

Low; isolated insider transaction.

Counterpoint

If the director is reducing exposure, it could signal concerns about near‑term performance.

Key entities

  • Knowles Corp

    US‑listed audio and semiconductor manufacturer (ticker KN).

  • Cheryl L. Shavers

    Director of Knowles Corp who sold 6,618 shares.

Related articles

$KNMed

Knowles Targets 30% Margins as Specialty Components Drive Growth

Knowles Corporation (KN) aims for 30% EBITDA margins within 36 months, driven by growth in specialty components. The company reported 11% EBITDA growth from 2017-2025, with recent organic growth exceeding 10%. Precision Devices is expected to grow over 15% this year, while hearing-health margins remain above 50% gross and 40% EBITDA. Knowles plans to reduce debt and continue selective acquisitions.

$ARGXHigh

argenx SE (ARGX) Halts Phase 3 UNITY Trial for Futility

argenx SE (ARGX) will halt its Phase 3 UNITY trial of efgartigimod SC in Sjögren's disease due to futility, following an IDMC recommendation. The company reports safety data were consistent with prior findings. This marks a setback in argenx's efforts to expand the drug's use in autoimmune diseases.